Nutraceutical Boom in Cancer: Inside the Labyrinth of Reactive Oxygen Species

Int J Mol Sci. 2020 Mar 12;21(6):1936. doi: 10.3390/ijms21061936.

Abstract

In recent years, epidemiological studies have shown that food is a very powerful means for maintaining a state of well-being and for health prevention. Many degenerative, autoimmune and neoplastic diseases are related to nutrition and the nutrient-organism interaction could define the balance between health and disease. Nutrients and dietary components influence epigenetic phenomena and modify drugs response; therefore, these food-host interactions can influence the individual predisposition to disease and its potential therapeutic response. Do nutraceuticals have positive or negative effects during chemotherapy? The use of nutraceutical supplements in cancer patients is a controversial debate without a definitive conclusion to date. During cancer treatment, patients take nutraceuticals to alleviate drug toxicity and improve long-term results. Some nutraceuticals may potentiate the effect of cytotoxic chemotherapy by inducing cell growth arrest, cell differentiation, and alteration of the redox state of cells, but in some cases, high levels of them may interfere with the effectiveness of chemotherapy, making cancer cells less reactive to chemotherapy. In this review, we highlighted the emerging opinions and data on the pros and cons on the use of nutraceutical supplements during chemotherapy.

Keywords: cancer; nutraceuticals; phenolic compounds.

Publication types

  • Review

MeSH terms

  • Animals
  • Diet / methods
  • Dietary Supplements*
  • Food-Drug Interactions / physiology
  • Humans
  • Neoplasms / metabolism*
  • Reactive Oxygen Species / metabolism*

Substances

  • Reactive Oxygen Species